These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 6195793

  • 1. [Limitations of tumor marker surveillance after chemotherapy in advanced non-seminomatous testicular tumors].
    Behrendt H, Ringert RH, Pfeiffer R, Homann W, Hartung R.
    Urol Int; 1983; 38(5):307-9. PubMed ID: 6195793
    [Abstract] [Full Text] [Related]

  • 2. [Staging of testicular cancer by ultrasound and tumor markers with special respect to stage I and IIA].
    Behrendt H, Heckemann R, Meyer-Schwickerath M, Hartung R.
    Urol Int; 1983; 38(5):279-84. PubMed ID: 6195792
    [Abstract] [Full Text] [Related]

  • 3. Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: current perspective.
    Skinner DG, Scardino PT.
    Trans Am Assoc Genitourin Surg; 1979; 71():31-5. PubMed ID: 94715
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The place of surgery in the treatment of seminomatous testicular tumors.
    Smith RB.
    Prog Clin Biol Res; 1984; 153():111-9. PubMed ID: 6206504
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tumor marker levels in post-chemotherapy cystic masses: clinical implications for patients with germ cell tumors.
    Beck SD, Patel MI, Sheinfeld J.
    J Urol; 2004 Jan; 171(1):168-71. PubMed ID: 14665869
    [Abstract] [Full Text] [Related]

  • 10. Tissue alpha-fetoprotein and human chorionic gonadotrophin in non-seminomatous testicular tumours. A comparative study with serum levels.
    Altug MU, Akdas A, Ruacan S, Ozen AH, Remzi D.
    Br J Urol; 1987 May; 59(5):458-62. PubMed ID: 2439163
    [Abstract] [Full Text] [Related]

  • 11. Prognostic significance of early serum tumor marker half-life in metastatic testicular teratoma.
    Stevens MJ, Norman AR, Dearnaley DP, Horwich A.
    J Clin Oncol; 1995 Jan; 13(1):87-92. PubMed ID: 7528272
    [Abstract] [Full Text] [Related]

  • 12. Elevated serum tumor markers in patients with testicular cancer after induction chemotherapy due to a reservoir of markers in cystic differentiated mature teratoma.
    van der Gaast A, Hoekstra JW, Croles JJ, Splinter TA.
    J Urol; 1991 Apr; 145(4):829-31. PubMed ID: 1706441
    [Abstract] [Full Text] [Related]

  • 13. Transient rise in tumor marker after initial adjuvant chemotherapy for testicular cancer.
    Wolf DJ, Williams JJ.
    Urology; 1982 Jul; 20(1):50-2. PubMed ID: 6180542
    [No Abstract] [Full Text] [Related]

  • 14. Immunohistochemistry of germ cell tumors of the testis. Study of beta HCG and AFP.
    Caillaud JM, Bellet D, Carlu C, Droz JP.
    Prog Clin Biol Res; 1985 Jul; 203():139-40. PubMed ID: 2421327
    [No Abstract] [Full Text] [Related]

  • 15. Serum tumour marker regression rate following chemotherapy for malignant teratoma.
    Horwich A, Peckham MJ.
    Eur J Cancer Clin Oncol; 1984 Dec; 20(12):1463-70. PubMed ID: 6209145
    [Abstract] [Full Text] [Related]

  • 16. Retroperitoneal metastases in testicular cancer: role of CT measurements of residual masses in decision making for resection after chemotherapy.
    Steyerberg EW, Keizer HJ, Sleijfer DT, Fossâ SD, Bajorin DF, Gerl A, de Wit R, Kirkels WJ, Koops HS, Habbema JD.
    Radiology; 2000 May; 215(2):437-44. PubMed ID: 10796922
    [Abstract] [Full Text] [Related]

  • 17. Germ cell tumours of the testis.
    Risdon RA.
    J Pathol; 1983 Nov; 141(3):355-61. PubMed ID: 6198501
    [Abstract] [Full Text] [Related]

  • 18. Prognostic factors in metastatic nonseminomatous germ cell tumours.
    Hanson PR, Belitsky P, Millard OH, Lannon SG.
    Can J Surg; 1993 Dec; 36(6):537-40. PubMed ID: 7504978
    [Abstract] [Full Text] [Related]

  • 19. Localization of alpha-fetoprotein and human chorionic gonadotropin to specific histologic types of nonseminomatous testicular cancer.
    Fowler JE, Sesterhenn I, Stutzman RE, Mostofi FK.
    Urology; 1983 Dec; 22(6):649-54. PubMed ID: 6196899
    [Abstract] [Full Text] [Related]

  • 20. Non-seminoma stage III. Current possibilities of "salvage" chemotherapy.
    Schmidt CG.
    Prog Clin Biol Res; 1984 Dec; 153():201-18. PubMed ID: 6206506
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.